
Chari A, Larson S, Holkova B, et al. Phase 1 trial of ibrutinib
Advertisement
Articles by Chari A, Larson S, Holkova B, et al. Phase 1 trial of ibrutinib

Advertisement
Latest Updated Articles
Study Summary: Ibrutinib Plus Carfilzomib for Relapsed or Relapsed/Refractory Multiple MyelomaPublished: October 18th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Respiratory Vaccination by the Numbers: COVID-19, Flu, and RSV
2
Inside the 24-Hour Reversal of SAMHSA Grant Cuts With NAMI's Jennifer Snow, MPA
3
Anti-Inflammatory, Antioxidant-Rich Diets May Lower Skin Cancer Risk, Slow Biological Aging
4
Lipid Management Remains Central to Cardiovascular Risk Reduction in CKD
5



